Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence

Aging and Cognitive FunctionsDementia

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

Brain.

Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative* and the PREVENT-AD Research Group

doi: 10.1093/brain/awy093.

Aging and Cognitive FunctionsPsychosis and Schizophrenia

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Transl Psychiatry.

Habtewold TD, Rodijk LH, Liemburg EJ, Sidorenkov G, Boezen HM, Bruggeman R, Alizadeh BZ

doi: 10.1038/s41398-020-00919-x.

Migraine and HeadachePsychosis and Schizophrenia

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Schizophr Res.

Durgam S, Earley W, Li R, Li D, Lu K, Laszlovszky I, Fleischhacker WW, Nasrallah HA

doi: 10.1016/j.schres.2016.06.030.

Aging and Cognitive FunctionsAnxiety and DepressionBipolar DisorderPsychosis and Schizophrenia

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial

Lancet Psychiatry.

Bockting CLH, Klein NS, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Buskens E, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H

doi: 10.1016/

Psychosis and Schizophrenia

Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis

JAMA Psychiatry.

Rosengard RJ, Malla A, Mustafa S, Iyer SN, Joober R, Bodnar M, Lepage M, Shah JL

Psychosis and Schizophrenia

The Latent Structure of Negative Symptoms in Schizophrenia

JAMA Psychiatry.

Strauss GP, Nuñez A, Ahmed AO, Barchard KA, Granholm E, Kirkpatrick B, Gold JM, Allen DN

doi: 10.1001/

Multiple Sclerosis

Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis

Mult Scler.

Ferrè L, Mogavero A, Clarelli F, Moiola L, Sangalli F, Colombo B, Martinelli V, Comi G, Filippi M, Esposito F

doi: 10.1177/1352458520961690.

Psychosis and Schizophrenia

Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

Lancet Psychiatry

Bighelli I, Rodolico A, García-Mieres H, Pitschel-Walz G, Hansen WP, Schneider-Thoma J, Siafis S, Wu H, Wang D, Salanti G, Furukawa TA, Barbui C, Leucht S

doi: 10.1016/S2215-0366(21)00243-1

Anxiety and DepressionPsychosis and Schizophrenia

The relationship between negative symptoms and depression in schizophrenia: a systematic review

Acta Psychiatr Scand.

Krynicki CR, Upthegrove R, Deakin JFW, Barnes TRE

doi: 10.1111/acps.12873.

Related content

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial

Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis

The Latent Structure of Negative Symptoms in Schizophrenia

Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis

Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

The relationship between negative symptoms and depression in schizophrenia: a systematic review